Research article · 14 Mar 2018
EditorialPublished 12 Apr 2017
Multi-Drug Resistant Gram-Negative Bacteria: Antibiotic-Resistance and New Treatment Strategies
Department of Public Health and Infectious Diseases, Policlinico Umberto I°, Sapienza University, Viale del Policlinico 155, Rome, Italy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
In this editorial, we treat the multi-drug-resistance of microorganisms such as Klebsiella pneumonia (Kp) and Acinetobacter baumanii and the issues concerning the management of these infections. Diseases caused by carbapenemase-resistant Kp (CR-Kp) represent an emerging threat worldwide due to high mortality rate and limited therapeutic options. Consequently innovative therapies have been suggested for their treatment. Colistin- based combinations are considered the milestone of the therapy for CR-Kp. They include meropenem+colistin, meropenem +colistin+tigecycline, the double carbapenem+colistin, tigecycline+colistin, colistin+gentamicin and even colistin +vancomycin. However, colistin use might be limited by its potential nephrotoxicity and resistance. Other antibiotic combinations concern the tigecycline with gentamicin, fosfomycin with aminoglycoside and ertapenem with meropenem. Thus, the double carbapenem-regimen might be considered as a suitable therapy in those subjects in whom previous antimicrobial combinations failed. New antibiotics such as ceftazidime-avibactam effective on CR-Kp and ceftolozane-tazobactam active against XDR (Extensively Drug Resistant) Pseudomonas aeruginosa are now being used in many countries. The mortality results to be lower in patients treated with antibiotic combinations than in those who underwent monotherapy. Efforts should be made by the clinicians in order to limit the widespread of these resistant microorganisms all over the world. Encouraging new solutions as bacteriophage therapy or biocides currently does not seem the right choice.
Keywords
Subjects
Pathology & Lab MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Opinion · 31 Jan 2025
The Role of Efflux Pumps in Antibiotic Resistance among Gram-Negative Bacteria
Conference abstract · 2017
Nauclea pobeguinii and Uapaca togoensis has the potential to fight against multi-drug resistant (MDR) gram negative bacteria and cancer cells lines
Research article · 3 May 2019
SCREENING OF ANTIBIOTIC RESISTANT GRAM NEGATIVE BACTERIA AND PLASMID PROFILING OF MULTI-DRUG RESISTANT ISOLATES PRESENT IN SEWAGE ASSOCIATED WITH HEALTH CARE CENTERS
Short communication · 31 Mar 2023
Antibiotic Resistance in Gram-Negative Bacteria: Mechanisms and Strategies for Control
More from this journal
The newest in Diagnostic Pathology: Open Access.
Research article · 28 Oct 2026
Fleischner Society-Guided Follow-up of Incidentally Detected Pulmonary Lesions During the COVID-19 Pandemic Enables Early Lung Cancer Detection While Avoiding Unnecessary Pulmonary Resection
Research article · 26 Oct 2026
Intraoperative Localization of Solid Pulmonary Tumors in Children Using Nebulized Indocyanine Green and Fluorescence Thoracoscopy
Research article · 17 Sep 2026
The Utility of Monocyte-to-High-Density Lipoprotein-Cholesterol Ratio (MHR) in Estimating Renal Function Impairment: Cross-Sectional Data from the National Health and Nutrition Examination Survey (NHANES) 2007-2018
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalDiagnostic Pathology: Open Access
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Maria Teresa Mascellino”
- BylineArticles whose byline prints “Massimiliano De Angelis”
- BylineArticles whose byline prints “Alessandra Oliva”
